These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30592484)

  • 1. Trends in Testosterone Prescribing for Age-related Hypogonadism in Men With and Without Heart Disease.
    Morden NE; Woloshin S; Brooks CG; Schwartz LM
    JAMA Intern Med; 2019 Mar; 179(3):446-448. PubMed ID: 30592484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone prescribing in men with depression and anxiety disorders.
    Javed Z; Kuo YF; Temple JR; Urban RJ; Holmes H; Baillargeon J
    Ann Epidemiol; 2020 Oct; 50():15-19.e8. PubMed ID: 32800673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and Patterns of Testosterone Therapy among U.S. Male Medicare Beneficiaries, 1999 to 2014.
    Zhou CK; Advani S; Chaloux M; Gibson JT; Yu M; Bradley M; Hoover RN; Cook MB
    J Urol; 2020 Jun; 203(6):1184-1190. PubMed ID: 31928462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypogonadism is not being sufficiently recognised in 99% of general practices/family doctor surgeries.
    Stedman M; Livingston M; Albanese M; Hackett G; Heald AH
    Int J Clin Pract; 2020 Feb; 74(2):e13445. PubMed ID: 31713967
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of the "aging male"].
    Diemer T; Hauck EW; Rohde V; Weidner W
    Urologe A; 2005 Oct; 44(10):1173-8. PubMed ID: 16151757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Patterns in Testosterone Prescribing After US FDA Safety Communication in 2014.
    Sankar A; Everhart AO; Jena AB; Jeffery MM; Ross JS; Shah ND; Karaca-Mandic P
    Jt Comm J Qual Patient Saf; 2023 Sep; 49(9):458-466. PubMed ID: 37380503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of testosterone prescription overuse.
    Jasuja GK; Bhasin S; Rose AJ
    Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):240-245. PubMed ID: 28248754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing hypogonadism and treating decisions in different parts of the world: shifts in patterns between 2006 and 2015.
    Gooren L
    Aging Male; 2016; 19(1):46-53. PubMed ID: 26550686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Testosterone Prescription and Public Health Concerns.
    Gabrielsen JS; Najari BB; Alukal JP; Eisenberg ML
    Urol Clin North Am; 2016 May; 43(2):261-71. PubMed ID: 27132584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study.
    Jasuja GK; Bhasin S; Reisman JI; Hanlon JT; Miller DR; Morreale AP; Pogach LM; Cunningham FE; Park A; Berlowitz DR; Rose AJ
    J Gen Intern Med; 2017 Mar; 32(3):304-311. PubMed ID: 27995426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in testosterone prescription during the release of society guidelines.
    Sellke N; Omil-Lima D; Sun HH; Tay K; Rhodes S; Loeb A; Thirumavalavan N
    Int J Impot Res; 2024 Jun; 36(4):380-384. PubMed ID: 37130972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irrational Exuberance in Testosterone Prescribing: When Will the Bubble Burst?
    Handelsman DJ
    Med Care; 2015 Sep; 53(9):743-5. PubMed ID: 26270825
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends in Testosterone Replacement Therapy Use from 2003 to 2013 among Reproductive-Age Men in the United States.
    Rao PK; Boulet SL; Mehta A; Hotaling J; Eisenberg ML; Honig SC; Warner L; Kissin DM; Nangia AK; Ross LS
    J Urol; 2017 Apr; 197(4):1121-1126. PubMed ID: 27789218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone therapy: where do the latest guidelines agree and differ?
    Pelzman DL; Hwang K
    Curr Opin Endocrinol Diabetes Obes; 2020 Dec; 27(6):397-403. PubMed ID: 33044244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with the initiation of testosterone replacement therapy in men from the 45 and Up Study.
    Cheng Y; Bateson D; Concepcion K; Stewart M; Lowy M; Sweeney S; Estoesta J; McGeechan K
    Aust J Gen Pract; 2018 Oct; 47(10):698-704. PubMed ID: 31195775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to male hypogonadism in primary care.
    Lawrence KL; Stewart F; Larson BM
    Nurse Pract; 2017 Feb; 42(2):32-37. PubMed ID: 28085783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
    Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
    Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population trends from 2000-2011 in nuclear myocardial perfusion imaging use.
    McNulty EJ; Hung YY; Almers LM; Go AS; Yeh RW
    JAMA; 2014 Mar; 311(12):1248-9. PubMed ID: 24668108
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors that may be influencing the rise in prescription testosterone replacement therapy in adult men: a qualitative study.
    Mascarenhas A; Khan S; Sayal R; Knowles S; Gomes T; Moore JE
    Aging Male; 2016 Jun; 19(2):90-5. PubMed ID: 26927629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacing testosterone in men.
    Drug Ther Bull; 1999 Jan; 37(1):3-6. PubMed ID: 10562768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.